ID   Caco-2-RCAr clone 2
AC   CVCL_HA82
DR   cancercelllines; CVCL_HA82
DR   Wikidata; Q54808319
RX   PubMed=10393089;
CC   Population: Caucasian.
CC   Selected for resistance to: UniProtKB; P02879; Ricinus communis ricin.
CC   Sequence variation: Mutation; HGNC; 583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 05-10-23; Version: 12
//
RX   PubMed=10393089; DOI=10.1042/bj3410323;
RA   Jackman M.R., Ellis J.A., Gray S.R., Shurety W., Luzio J.P.;
RT   "Cell polarization is required for ricin sensitivity in a Caco-2 cell
RT   line selected for ricin resistance.";
RL   Biochem. J. 341:323-327(1999).
//